Bifogade filer
PDF
Kurs
-0,58%
Likviditet
7,21 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2025-11-05 | 07:50 | Kvartalsrapport 2025-Q3 |
| 2025-07-24 | 07:50 | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | N/A | X-dag ordinarie utdelning MCOV B 1.69 SEK |
| 2025-04-29 | N/A | Årsstämma |
| 2025-04-29 | 07:50 | Kvartalsrapport 2025-Q1 |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-10-30 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-25 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-29 | - | X-dag ordinarie utdelning MCOV B 1.35 SEK |
| 2024-04-26 | - | Årsstämma |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-11-03 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-26 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | X-dag ordinarie utdelning MCOV B 1.37 SEK |
| 2023-04-27 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-22 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | X-dag ordinarie utdelning MCOV B 1.25 SEK |
| 2022-04-27 | - | Årsstämma |
| 2022-04-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-11 | - | Bokslutskommuniké 2021 |
| 2021-11-03 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-23 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-30 | - | X-dag ordinarie utdelning MCOV B 0.71 SEK |
| 2021-04-29 | - | Årsstämma |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-12 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-24 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-04 | - | X-dag ordinarie utdelning MCOV B 0.00 SEK |
| 2020-04-30 | - | Årsstämma |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-06 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-26 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-06 | - | X-dag ordinarie utdelning MCOV B 0.00 SEK |
| 2019-05-03 | - | Årsstämma |
| 2019-05-03 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-10-26 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-27 | - | X-dag ordinarie utdelning MCOV B 0.00 SEK |
| 2018-04-26 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-09 | - | Bokslutskommuniké 2017 |
| 2017-10-27 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-28 | - | Kvartalsrapport 2017-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Medicover has acquired 88.8 per cent of the voting rights of the Danish sperm bank SellmerDiers from the two founders, Liza Diers and Anette Sellmer. SellmerDiers operates in three cities Aarhus, Copenhagen and Aalborg and is the third largest European sperm bank. SellmerDiers was acquired for 13.7 MEUR plus earn-out linked to future performance and reported revenue of 4.0 MEUR in 2020. The acquisition is an important strategic addition to Medicover's existing fertility business.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
The information was provided for publication by the abovementioned contact person at 20.30 CEST on 3 August 2021.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities,laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of EUR 998 million and more than 32,000 employees. For more information, go to www.medicover.com